The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 11, 2021

Filed:

Apr. 11, 2019
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Adam R. Abate, Daly City, CA (US);

Dennis Jay Eastburn, Burlingame, CA (US);

Adam R. Sciambi, San Francisco, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12P 19/34 (2006.01); C12Q 1/6886 (2018.01); C12Q 1/6806 (2018.01); B01L 3/00 (2006.01); B01L 7/00 (2006.01); B01F 5/06 (2006.01); B01F 13/00 (2006.01); B01F 3/08 (2006.01); C12Q 1/686 (2018.01); C12Q 1/6844 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); B01F 3/0807 (2013.01); B01F 5/0652 (2013.01); B01F 13/0062 (2013.01); B01F 13/0076 (2013.01); B01L 3/502784 (2013.01); B01L 7/52 (2013.01); C12Q 1/6806 (2013.01); C12Q 1/686 (2013.01); C12Q 1/6844 (2013.01); B01L 2200/0652 (2013.01); B01L 2300/0816 (2013.01); B01L 2300/0864 (2013.01); B01L 2300/0867 (2013.01); B01L 2300/0883 (2013.01); B01L 2300/1822 (2013.01); B01L 2400/0415 (2013.01); B01L 2400/0487 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/16 (2013.01);
Abstract

The disclosed embodiments generally relate to a method and system to synthesize a target molecule within a droplet. In an exemplary embodiment, a first microfluidic device configured to contact a polynucleotide-containing component from a sample with lysis reagents to form a first droplet. The lysis reagents include an enzyme having protease activity. The first droplet is encapsulated with an immiscible carrier fluid. A collection reservoir is provided to receive and incubate the first droplet for a first duration of time. The first duration of time is sufficient to inactivate the enzyme of the lysis reagent. A second microfluidic device is provided to receive the first droplet and add nucleic acid synthesis reagent to thereby form a second nucleic acid synthesis droplet in the immiscible carrier fluid. Finally, a reaction chamber is provided to synthesize the target polynucleotide within the second nucleic acid synthesis droplet.


Find Patent Forward Citations

Loading…